NEIM-01. PREDICTION OF RESPONSE TO COMBINATION OF NIVOLUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA VIA RADIOMIC ANALYSIS ON CLINICAL MRI SCANS

Manmeet Ahluwalia

NEIM-01. PREDICTION OF RESPONSE TO COMBINATION OF NIVOLUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA VIA RADIOMIC ANALYSIS ON CLINICAL MRI SCANS

Manmeet Ahluwalia

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Neuro-Oncology Advances
Volume	3
State	Published - Oct 1 2021

Access to Document

ViewcontentFinal published version, 20.4 KBLicense: Unspecified

Cite this

@article{badef25aebbe490ea585e6aeaed5e3eb,

title = "NEIM-01. PREDICTION OF RESPONSE TO COMBINATION OF NIVOLUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA VIA RADIOMIC ANALYSIS ON CLINICAL MRI SCANS",

author = "Manmeet Ahluwalia",

note = "Neuro-Oncology Advances (2021) 3(Supplement\_4):iv6-iv6",

year = "2021",

month = oct,

day = "1",

language = "American English",

volume = "3",

journal = "Neuro-Oncology Advances",

}

TY - JOUR

T1 - NEIM-01. PREDICTION OF RESPONSE TO COMBINATION OF NIVOLUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA VIA RADIOMIC ANALYSIS ON CLINICAL MRI SCANS

AU - Ahluwalia, Manmeet

N1 - Neuro-Oncology Advances (2021) 3(Supplement_4):iv6-iv6

PY - 2021/10/1

Y1 - 2021/10/1

UR - https://scholarlycommons.baptisthealth.net/se-all-publications/4211

M3 - Article

VL - 3

JO - Neuro-Oncology Advances

JF - Neuro-Oncology Advances

ER -

NEIM-01. PREDICTION OF RESPONSE TO COMBINATION OF NIVOLUMAB AND BEVACIZUMAB IN PATIENTS WITH RECURRENT GLIOBLASTOMA VIA RADIOMIC ANALYSIS ON CLINICAL MRI SCANS

Access to Document

Other files and links

Cite this